Foreseen Biotechnology
We innovate for patients
Taipei, Taiwan · Founded 2021
- Headquarters
- Taipei
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- foreseenbio.com
About
Foreseen Biotechnology is a precision medicine company founded in 2021 by proteomics leader Catherine C.L. Wong and backed by Sequoia China. The company has built a proprietary high-throughput proteomics and multi-omics platform — including SurfSEEN for membrane-protein discovery and PrOmics for AI-assisted target prioritization — to identify novel, clinically translatable disease targets. Its pipeline spans oncology, autoimmune, and neurological diseases, with lead program FS001 (IPN60300), a first-in-class antibody-drug conjugate, licensed to Ipsen in 2024 and currently in Phase I/II clinical trials in the US and Europe.
Summary
Foreseen Biotechnology is a Biotech company based in Taipei, Taiwan, founded in 2021.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...